Name | N-[3,5-Bis(trifluoromethyl)benzyl]-N-methyl-4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)nicotinamide |
---|---|
Synonyms |
3-Pyridinecarboxamide, N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-N-methyl-4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-
N-[3,5-Bis(trifluoromethyl)benzyl]-N-methyl-4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)nicotinamide N-[3,5-bis(trifluoromethyl)benzyl]-N-methyl-4-(2-methylphenyl)-6-(4-methylpiperazin-1-yl)pyridine-3-carboxamide |
Description | Imnopitant is a NK1 receptor antagonist (WO2020132716, compound 1) [1]. |
---|---|
Related Catalog | |
Target |
NK1 |
In Vitro | Imnopitant is a NK1 receptor antagonist[1]. |
References |
[1]. WO2020132716 |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 606.5±55.0 °C at 760 mmHg |
Molecular Formula | C28H28F6N4O |
Molecular Weight | 550.54 |
Flash Point | 320.6±31.5 °C |
Exact Mass | 550.216736 |
LogP | 4.65 |
Vapour Pressure | 0.0±1.7 mmHg at 25°C |
Index of Refraction | 1.540 |